quite significantP = 2.7 × 10 -10
In the case of the topoisomerase II inhibitors, 12% of the etoposide-associated CNVs were found to associate with daunorubicin IC 50 , and the observed overlap is still quite significant ( P = 2.7 × 10 -10 ).
In the case of the topoisomerase II inhibitors, 12% of the etoposide-associated CNVs were found to associate with daunorubicin IC 50 , and the observed overlap is still quite significant ( P = 2.7 × 10 -10 ).